5 unknown, 2 completed, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Unknown 2 |
Follow New Discovery LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US iLivTouch, FibroScan - Liver Fibrosis, Fatty Liver | Unknown | New Discovery LLC | 418 | 2023-09-24 | 2023-10-13 | |
| Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides Tenofovir Alafenamide 25 MG - Hepatitis B, Chronic | Phase 4 | Unknown | New Discovery LLC | 100 | 2021-05-01 | 2020-11-17 |
| Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B Tenofovir Alafenamide 25 MG for arm (A), Tenofovir Disoproxil Fumarate 300mg for arm (B) - Hepatitis B, Chronic, Pregnancy Related | Unknown | New Discovery LLC | 450 | 2020-01-27 | 2020-12-29 | |
| Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Vertical Transmission Tenofovir Alafenamide 25 MG, Tenofovir Disoproxil Fumarate 300 MG Oral Tablet - Hepatitis B, Chronic, Pregnancy Related | Unknown | New Discovery LLC | 600 | 2019-04-09 | 2020-01-23 | |
| Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission Tenofovir Disoproxil Fumarate (TDF) 300 mg oral daily. - Hepatitis B Infection, Congenital Malformation | Phase 4 | Unknown | New Discovery LLC | 280 | 2018-06-10 | 2019-12-12 |
| Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment Tenofovir Disoproxil Fumarate, Entecavir - Hepatitis B | Terminated | New Discovery LLC | 48 | 2012-10-01 | 2017-09-06 | |
| Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus TDF treatment - Hepatitis B Infection, Chronic Infection | Phase 4 | Completed | New Discovery LLC | 200 | 2012-03-01 | 2019-12-09 |
| Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B Telbivudine, Lamivudine - Chronic Hepatitis B, Late Pregnancy | Phase 4 | Completed | Beijing YouAn Hospital | 700 | 2009-01-01 | 2013-07-30 |
Hepatitis B, Chronic (4) · Hepatitis B (3) · Persistent Infection (2) · Viremia (2) · Congenital Abnormalities (1) · Fatty Liver (1) · Liver Cirrhosis (1)
Tenofovir (5) · tenofovir alafenamide (3) · hepatitis B hyperimmune globulin (2) · Hepatitis B Vaccines (1) · Lamivudine (1) · Tablets (1) · Telbivudine (1) · entecavir (1) · lipoarabinomannan (1)
China (6) · United States (2)
Calvin Q Pan, MD (4) · Calvin Pan, MD (2) · Erhei Dai, MD (2) · Zhongping Duan, MD (2) · Calvin Q Pan, M.D. (1) · Calvin Q. Pan (1) · Guorong Han, MD (1) · Hua Zhang, MD (1) · Huaihong Zhang, MD (1) · Shuqin Zhang, MD (1) · Wen Xie, MD (1) · Yuming Wang, MD (1)
PMID 25187919, PMID 27305192, PMID 33789963, PMID 39540799, PMID 39953819